ID   LK2
AC   CVCL_W132
DR   cancercelllines; CVCL_W132
DR   Cosmic; 1609531
DR   GEO; GSM313666
DR   Progenetix; CVCL_W132
DR   Wikidata; Q54902670
RX   PubMed=1892748;
RX   PubMed=15677628;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 9
//
RX   PubMed=15677628; DOI=10.1093/carcin/bgi032;
RA   Gorringe, Kylie Louise
RA   Chin, Suet-Feung
RA   Pharoah, Paul D.P.
RA   Staines, Joanne M.
RA   Oliveira, Carla
RA   Edwards, Paul A.W.
RA   Caldas, Carlos
RT   "Evidence that both genetic instability and selection contribute to
RT   the accumulation of chromosome alterations in cancer.";
RL   Carcinogenesis 26:923-930(2005).
//
RX   PubMed=1892748; DOI=10.1038/bjc.1991.279; PMCID=PMC1977519;
RA   Mistry, Prakash
RA   Kelland, Lloyd R.
RA   Abel, George
RA   Sidhar, Sanjiv
RA   Harrap, Kenneth Reginald
RT   "The relationships between glutathione, glutathione-S-transferase and
RT   cytotoxicity of platinum drugs and melphalan in eight human ovarian
RT   carcinoma cell lines.";
RL   Br. J. Cancer 64:215-220(1991).
//